PatientsVille.com Logo

PatientsVille

Reslin Side Effects

Common Reslin Side Effects


The most commonly reported Reslin side effects (click to view or check a box to report):

Neuroleptic Malignant Syndrome (7)
Suicide Attempt (4)
Renal Failure Acute (4)
Delirium (3)
Blood Creatine Phosphokinase Increased (2)
Coma (2)
Altered State Of Consciousness (2)
Aspartate Aminotransferase Increased (2)
Quadriplegia (2)
Pancytopenia (2)
Liver Disorder (2)
Somnolence (1)
Supraventricular Tachycardia (1)
Serotonin Syndrome (1)
Sudden Death (1)
Rhabdomyolysis (1)
Pneumonia (1)
Pulmonary Thrombosis (1)
Self Injurious Behaviour (1)
Septic Shock (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Reslin Side Effects Reported to FDA

The following Reslin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Reslin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

This is a report of a 55-year-old male patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: NA, who was treated with Reslin (dosage: NA, start time: Dec 01, 2007), combined with:
  • Risperdal
  • Abilify
  • Ubretid
  • Benzalin
  • Halcion
  • Hiberna
  • Seroquel (500-600 Mg Daily)
  • Hirnamin
and developed a serious reaction and side effect(s). The consumer presented with:
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Reslin treatment in male patients, resulting in sudden death side effect.

    Cataract, Somnolence
    This report suggests a potential Reslin Cataract, Somnolence side effect(s) that can have serious consequences. A 60-year-old female patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: NA and used Reslin (dosage: Unk) starting Mar 01, 2009. Soon after starting Reslin the patient began experiencing various side effects, including:
    • Cataract
    • Somnolence
    Drugs used concurrently:
    • Loramet (Unk)
    • Wypax (Unk)
    • Toledomin (Unk)
    • Seroquel (50 Mg)
    • Seroquel (25 Mg)
    • Seroquel (12.5 Mg)
    • Myslee (5 Mg)
    Although Reslin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as cataract, may still occur.

    Inappropriate Antidiuretic Hormone Secretion, Rhabdomyolysis
    This Inappropriate Antidiuretic Hormone Secretion, Rhabdomyolysis problem was reported by a health professional from ITALY. A 64-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: adjustment disorder. On Nov 30, 2007 this consumer started treatment with Reslin (dosage: NA). The following drugs were being taken at the same time:
    • Sulpiride
    • Bezafibrate
    • Bezafibrate
    When commencing Reslin, the patient experienced the following unwanted symptoms/side effects:
    • Inappropriate Antidiuretic Hormone Secretion
    • Rhabdomyolysis
    The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as inappropriate antidiuretic hormone secretion, may become evident only after a product is in use by the general population.

    Delayed Recovery From Anaesthesia
    This is a report of a 77-year-old female patient (weight: NA) from ITALY. The patient developed the following symptoms/conditions: obsessive-compulsive disorder and was treated with Reslin (dosage: NA) starting NS. Concurrently used drugs:
    • Fluvoxamine Maleate
    • Propofol
    • Fentanyl
    • Remifentanil Hcl
    • Musculax
    • Naropin
    Soon after that, the consumer experienced the following side effects:
    • Delayed Recovery From Anaesthesia
    This opens a possibility that Reslin treatment could cause the above reactions, including delayed recovery from anaesthesia, and some female subjects may be more susceptible.


    Serotonin Syndrome
    A 83-year-old female patient (weight: NA) from ITALY with the following symptoms/conditions: anxiety disorder started Reslin treatment (dosage: NA) on NS. Soon after starting Reslin treatment, the subject experienced various side effects, including:
    • Serotonin Syndrome
    Concurrently used drugs:
    • Paroxetine Hcl
    • Donepezil Hcl
    • Risperidone (Dose Was Decreased To 0.5 Mg And Again Increased To 1 Mg)
    • Quetiapine Fumarate
    The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Reslin.

    Coma, Suicide Attempt
    A 20-year-old female patient from ITALY (weight: NA) experienced symptoms, such as: NA and was treated with Reslin(dosage: NA). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
    • Coma
    • Suicide Attempt
    Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Reslin efficacy:
    • Lendormin
    The patient was hospitalized.

    Altered State Of Consciousness, Delirium
    In this report, Reslin was administered for the following condition: delirium.A 70-year-old female consumer from JAPAN (weight: NA) started Reslin treatment (dosage: NA) on Jan 01, 2003.Sometime after starting the treatment, the patient complained of the following side effect(s):
    • Altered State Of Consciousness
    • Delirium
    A possible interaction with other drugs could have contributed to this reaction: NA.The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Reslin treatment could be related to the listed above side effect(s).

    Ventouse Extraction
    This is a report of the following Reslin side effect(s):
    • Ventouse Extraction
    A 28-year-old female patient from UNITED STATES (weight: NA) presented with the following condition: depression and received a treatment with Reslin (dosage: 25 Mg, Tid) starting: Sep 01, 2007.The following concurrently used drugs could have generated interactions:
    • Amoxapine (25 Mg, Tid)
    • Solanax (0.4 Mg, Qd)
    • Tofranil (25 Mg, Tid)
    The patient was hospitalized.This report suggests that a Reslin treatment could be associated with the listed above side effect(s).

    Agranulocytosis, Pancytopenia, Septic Shock
    This Reslin report was submitted by a 79-year-old male consumer from ITALY (weight: NA). The patient was diagnosed with: depression,anorexia,anxiety and Reslin was administered (dosage: NA) starting: Oct 09, 2007. The consumer developed a set of symptoms:
    • Agranulocytosis
    • Pancytopenia
    • Septic Shock
    Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Reslin treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

    Pancytopenia
    This is a report of a possible correlation between Reslin use and the following symptoms/side effect(s):
    • Pancytopenia
    which could contribute to an assessment of Reslin risk profile.A 79-year-old male consumer from ITALY (weight: NA) was suffering from depression and was treated with Reslin (dosage: NA) starting Oct 09, 2007.Other concurrent medications:
    • Dogmatyl
    • Paxil
    • Meilax
    • Depas


    Altered State Of Consciousness, Thirst
    A 62-year-old male patient from ITALY (weight: NA) presented with the following symptoms: depression and after a treatment with Reslin (dosage: NA) experienced the following side effect(s):
    • Altered State Of Consciousness
    • Thirst
    The treatment was started on Jan 01, 2001. Reslin was used in combination with the following drugs: NA.The patient was hospitalized.This report could alert potential Reslin consumers.

    Neuroleptic Malignant Syndrome, Quadriplegia, Renal Failure Acute, Suicide Attempt
    In this report, a 44-year-old male patient from JAPAN (weight: NA) was affected by a possible Reslin side effect.The patient was diagnosed with depression,insomnia. After a treatment with Reslin (dosage: NA, start date: NS), the patient experienced the following side effect(s):
    • Neuroleptic Malignant Syndrome
    • Quadriplegia
    • Renal Failure Acute
    • Suicide Attempt
    The following simultaneously used drugs could have led to this reaction:
    • Triazolam
    • Chlorpromazine Hcl
    • Promethazine
    • Phenobarbital Tab
    • Tandospirone Citrate
    • Rilmazafone Hcl
    The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Reslin treatment.

    Delirium, Neuroleptic Malignant Syndrome, Quadriplegia, Renal Failure Acute
    This is a report of a 59-year-old male patient from JAPAN (weight: NA), who used Reslin (dosage: NA) for a treatment of depression. After starting a treatment on NS, the patient experienced the following side effect(s):
    • Delirium
    • Neuroleptic Malignant Syndrome
    • Quadriplegia
    • Renal Failure Acute
    The following drugs could possibly have interacted with the Reslin treatment
    • Ludiomil
    • Dogmatyl
    • Tryptanol
    • Perphenazine
    • Depas
    • Biperiden Hydrochloride Tab
    • Risumic
    • Promethazine
    The patient was hospitalized.Taken together, these observations suggest that a Reslin treatment could be related to side effect(s), such as Delirium, Neuroleptic Malignant Syndrome, Quadriplegia, Renal Failure Acute.

    Platelet Count Decreased, White Blood Cell Count Decreased
    This platelet count decreased side effect was reported by a health professional from ITALY. A 80-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Reslin (dosage: NA), which was started on NS. Concurrently used drugs: NA. When starting to take Reslin the consumer reported the following symptoms:
    • Platelet Count Decreased
    • White Blood Cell Count Decreased
    The patient was hospitalized. These side effects may potentially be related to Reslin.

    Neuroleptic Malignant Syndrome, Renal Failure Acute, Suicide Attempt
    This is a Reslin side effect report of a 44-year-old male patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: NA, who was treated with Reslin (dosage:NA, start time: NS), combined with:
    • Triazolam
    • Chlorpromazine Hcl
    • Promethazine
    • Phenobarbital Tab
    • Tandospirone Citrate
    • Rilmazafone Hcl
    , and developed a serious reaction and a neuroleptic malignant syndrome side effect. The patient presented with:
    • Neuroleptic Malignant Syndrome
    • Renal Failure Acute
    • Suicide Attempt
    which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Reslin treatment in male patients suffering from NA, resulting in neuroleptic malignant syndrome.

    Delirium, Neuroleptic Malignant Syndrome, Renal Failure Acute
    This report suggests a potential Reslin delirium side effect(s) that can have serious consequences. A 49-year-old male patient from JAPAN (weight:NA) was diagnosed with the following health condition(s): NA and used Reslin (dosage: NA) starting NS. Soon after starting Reslin the patient began experiencing various side effects, including:
    • Delirium
    • Neuroleptic Malignant Syndrome
    • Renal Failure Acute
    Drugs used concurrently:
    • Maprotiline Hcl
    • Sulpiride
    • Amitriptyline Hcl
    The patient was hospitalized. Although Reslin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as delirium, may still occur.

    Coma, Neuroleptic Malignant Syndrome, Suicide Attempt
    This coma problem was reported by a health professional from ITALY. A 21-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Sep 20, 2006 a consumer started treatment with Reslin (dosage: NA). The following drugs/medications were being taken at the same time:
    • Limas
    • Dogmatyl
    • Lorazepam
    When commencing Reslin, the patient experienced the following unwanted symptoms /side effects:
    • Coma
    • Neuroleptic Malignant Syndrome
    • Suicide Attempt
    The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as coma, may become evident only after a product is in use by the general population.

    Pulmonary Thrombosis
    This is a Reslin side effect report of a 52-year-old male patient (weight: NA) from ITALY. The patient developed the following symptoms/conditions: insomnia,alcoholic psychosis and was treated with Reslin (dosage: NA) starting Jan 01, 1992. Concurrently used drugs:
    • Vegetamin
    • Lullan
    • Eurodin
    • Meilax
    • Amoban
    • Rohipnol
    • Lodopin
    • Myslee
    Soon after that, the consumer experienced the following of symptoms:
    • Pulmonary Thrombosis
    The patient was hospitalized. This opens a possibility that Reslin could cause pulmonary thrombosis and that some male patients may be more susceptible.

    Self Injurious Behaviour
    A 26-year-old female patient (weight: NA) from JAPAN with the following symptoms: NA started Reslin treatment (dosage: NA) on Jul 24, 2006. Soon after starting Reslin treatment, the consumer experienced several side effects, including:
    • Self Injurious Behaviour
    . Concurrently used drugs:
    • Solanax (24/7/06-30/7/06 .800 Mg Qd,31/7/06-20/8/06 .400 Mg, 21/8/06-cont .800 Mg 10/7-23/7/06 1.200 Mg)
    • Zoloft (10/7/06-17/7/06 50 Mg Qd, 18/7/06-23/7/06 75 Mg Qd, 24/7/06-20/8/06 100 Mg Qd)
    • Depas
    • Myslee
    • Nitrazepam
    • Famotidine
    • Nitrazepam
    This finding indicates that some patients can be more vulnerable to developing Reslin side effects, such as self injurious behaviour.

    Liver Disorder, Systemic Lupus Erythematosus
    This liver disorder side effect was reported by a consumer or non-health professional from UNITED STATES. A 72-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Reslin (dosage: NA), which was started on Aug 01, 2004. Concurrently used drugs:
    • Sulpiride
    • Xanax
    • Tolazoline Hcl
    .When starting to take Reslin the consumer reported symptoms, such as:
    • Liver Disorder
    • Systemic Lupus Erythematosus
    These side effects may potentially be related to Reslin. The patient was hospitalized.

    Neuroleptic Malignant Syndrome
    This is a report of a 21-year-old female patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: NA, who was treated with Reslin (dosage: NA, start time: Sep 20, 2006), combined with:
    • Limas
    • Dogmatyl
    • Lorazepam
    and developed a serious reaction and side effect(s). The consumer presented with:
    • Neuroleptic Malignant Syndrome
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Reslin treatment in female patients, resulting in neuroleptic malignant syndrome side effect. The patient was hospitalized.

    Neuroleptic Malignant Syndrome
    This report suggests a potential Reslin Neuroleptic Malignant Syndrome side effect(s) that can have serious consequences. A 79-year-old male patient (weight: NA) from ITALY was diagnosed with the following symptoms/conditions: NA and used Reslin (dosage: NA) starting NS. Soon after starting Reslin the patient began experiencing various side effects, including:
    • Neuroleptic Malignant Syndrome
    Drugs used concurrently:
    • Haloperidol
    • Biperiden Hydrochloride Tab
    • Zopiclone
    The patient was hospitalized. Although Reslin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as neuroleptic malignant syndrome, may still occur.

    Anxiety, Dyspnoea, Hyperhidrosis, Hypovolaemic Shock, Supraventricular Tachycardia
    This Anxiety, Dyspnoea, Hyperhidrosis, Hypovolaemic Shock, Supraventricular Tachycardia problem was reported by a health professional from JAPAN. A 75-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: depression. On May 01, 2005 this consumer started treatment with Reslin (dosage: NA). The following drugs were being taken at the same time:
    • Tofranil
    • Flivas
    • Pimenol
    • Blopress
    • Norvasc
    • Primperan Tab
    • Adetphos
    • Acecol
    When commencing Reslin, the patient experienced the following unwanted symptoms/side effects:
    • Anxiety
    • Dyspnoea
    • Hyperhidrosis
    • Hypovolaemic Shock
    • Supraventricular Tachycardia
    The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as anxiety, may become evident only after a product is in use by the general population.

    Completed Suicide
    This is a report of a 25-year-old female patient (weight: NA) from ITALY. The patient developed the following symptoms/conditions: NA and was treated with Reslin (dosage: NA) starting NS. Concurrently used drugs:
    • Migsis
    • Halcion
    Soon after that, the consumer experienced the following side effects:
    • Completed Suicide
    This opens a possibility that Reslin treatment could cause the above reactions, including completed suicide, and some female subjects may be more susceptible.

    Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased
    A 58-year-old male patient (weight: NA) from ITALY with the following symptoms/conditions: insomnia,gastritis,hyperlipidaemia started Reslin treatment (dosage: NA) on Aug 13, 2003. Soon after starting Reslin treatment, the subject experienced various side effects, including:
    • Aspartate Aminotransferase Increased
    • Blood Creatine Phosphokinase Increased
    • Blood Lactate Dehydrogenase Increased
    Concurrently used drugs:
    • Takepron
    • Lipovas
    • Amoban
    • Gaslon N
    • Diart
    • Thyradin S
    • Paraclodin
    • Isosorbide Mononitrate
    The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Reslin.

    1 of 2 



    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Reslin Side Effects

    Did You Have a Reslin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Reslin for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Reslin Safety Alerts, Active Ingredients, Usage Information

    More About Reslin

    Side Effects reported to FDA: 28

    Reslin safety alerts: No

    Reported deaths: 3

    Reported hospitalizations: 22

    Latest Reslin clinical trials

    Reslin Reviews

    No reviews, be a first to report a side effect via side effect reporting form